Tactile systems CFO sells shares valued at $55,538

Published 25/02/2025, 00:26
Tactile systems CFO sells shares valued at $55,538

Elaine M. Birkemeyer, the Chief Financial Officer of Tactile Systems Technology Inc . (NASDAQ:TCMD), recently reported a sale of company stock. On February 24, 2025, Birkemeyer sold 3,778 shares of common stock at a weighted average price of approximately $14.70 per share, totaling $55,538. This transaction was part of a pre-established 10b5-1 trading plan adopted on June 10, 2024. The sale comes as the $359 million market cap company maintains strong financial health, with a current ratio of 4.36 and robust cash flows that adequately cover its debt obligations.According to InvestingPro analysis, TCMD currently appears undervalued, with additional insights available in the comprehensive Pro Research Report, one of 1,400+ deep-dive analyses available to subscribers.

The shares sold were to cover taxes associated with the settlement of stock units. Following this transaction, Birkemeyer retains direct ownership of 104,098 shares of Tactile Systems Technology, demonstrating continued alignment with shareholder interests as the company maintains a healthy 74% gross profit margin and positive earnings yield.

In other recent news, Tactile Systems Technology Inc. reported its fourth-quarter 2024 financial results, revealing a revenue of $85.6 million, which surpassed the expected $85.41 million. The company also achieved earnings per share of $0.40, exceeding the forecast of $0.31. Despite these positive results, analysts at B.Riley downgraded Tactile Systems from Buy to Neutral, reducing the price target to $18 from $23. This downgrade was influenced by concerns over slowing earnings growth and ongoing legal challenges. Tactile Systems has projected fiscal year 2025 sales to range between $316 million and $322 million, aligning with analyst expectations, but its adjusted EBITDA guidance fell short of consensus estimates. The company has emphasized its focus on expanding its product lines and improving patient access to care. However, the adjusted EBITDA projection for 2025 indicates a potential year-over-year growth decline, contrasting with previous years’ significant growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.